Holiday Sale | Save 50%
Holiday Sale | Save 50%
Published

UK Health Authority Endorses Drug to Prevent Pediatric Hearing Loss from Cancer Treatment | Hearing Health & Technology Matters

Summary by hearinghealthmatters.org
LONDON, UNITED KINGDOM — The National Institute for Health and Care Excellence (NICE) has recommended a new treatment aimed at preventing and reducing hearing loss in patients undergoing cisplatin chemotherapy. This marks a significant step forward in addressing a common and often debilitating side effect of a widely used cancer treatment. Cisplatin is a chemotherapy drug commonly administered to treat various forms of cancer, including testicul…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)